Expression analysis of TOP2A, MSH2 and MLH1 genes in MCF7 cells at different levels of etoposide resistance

Date

2012-02-01

Author

Kaplan, Esra
Gündüz, Ufuk

Metadata

Show full item record

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Item Usage Stats

11
views

0
downloads

Purpose: Development of resistance against anti-cancer drugs is one of the major obstacles of chemotherapy in the treatment of cancer. Etoposide is a topoisomerase II alpha (TOP2A) inhibitor, which is used in the treatment of breast cancer. Alterations in the expression of drug targets or DNA repair genes are among the important resistance mechanisms against TOP2A inhibitors. In this study, expression changes in TOP2A gene and two important mismatch repair (MMR) genes MSH2 and MLH1 were examined in order to understand the relationship between differential expression of these genes and drug resistance against etoposide.

Subject Keywords

Breast cancer, Chemotherapy resistance, Etoposide

URI

https://hdl.handle.net/11511/31393

Journal

BIOMEDICINE & PHARMACOTHERAPY

DOI

https://doi.org/10.1016/j.biopha.2011.09.002

Collections

Graduate School of Natural and Applied Sciences, Article

Citation Formats

E. Kaplan and U. Gündüz, “Expression analysis of TOP2A, MSH2 and MLH1 genes in MCF7 cells at different levels of etoposide resistance,” BIOMEDICINE & PHARMACOTHERAPY, vol. 66, no. 1, pp. 29–35, 2012, Accessed: 00, 2020. [Online]. Available: https://hdl.handle.net/11511/31393.